Introduction: Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in
patients with chronic obstructive pulmonary disease. To estimate the association between …

Background: Whether all types of inhaled corticosteroids (ICSs) would increase the
pneumonia risk in patients with chronic obstructive pulmonary disease (COPD) remains …

Introduction Observational studies using case-control designs have showed an increased
risk of pneumonia associated with inhaled corticosteroid (ICS)-containing medications in …

Objective Inhaled corticosteroids (ICS) are generally used to treat patients with chronic
obstructive pulmonary disease (COPD) who suffer from repeated exacerbations. Recently, it …

There is a considerable amount of evidence that supports the possibility of an increased risk
of pneumonia associated with prolonged use of inhaled corticosteroids (ICS) in patients with …

Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of
infections such as pneumonia. Pneumonia among patients with COPD carries a higher risk …

Background Use of inhaled corticosteroids (ICS) increases the risk of pneumonia in chronic
obstructive pulmonary disease (COPD), but the magnitude of risk with different ICS remains …

Background: Inhaled corticosteroids are commonly prescribed for patients with severe
COPD. They have been associated with increased risk of pneumonia but not with increased …

Background The use of inhaled corticosteroids (ICS) in combination with bronchodilators in
patients with COPD has been shown to decrease the rate of disease exacerbations and to …

Background The widespread use of inhaled corticosteroids (ICSs) for COPD treatment has
been questioned. Recent studies of weaning some patients with COPD off ICSs found little …